Vladimir V Kalinichenko Selected Research

Transcription Factors (Transcription Factor)

1/2023	Single Cell Multiomics Identifies Cells and Genetic Networks Underlying Alveolar Capillary Dysplasia.
1/2021	FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.
12/2020	Disruption of a hedgehog-foxf1-rspo2 signaling axis leads to tracheomalacia and a loss of sox9+ tracheal chondrocytes.
1/2020	Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice.
1/2020	FOXM1 nuclear transcription factor translocates into mitochondria and inhibits oxidative phosphorylation.
1/2020	Nanoparticle Delivery of Proangiogenic Transcription Factors into the Neonatal Circulation Inhibits Alveolar Simplification Caused by Hyperoxia.
2/2019	The Forkhead box F1 transcription factor inhibits collagen deposition and accumulation of myofibroblasts during liver fibrosis.
1/2019	The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear β-Catenin.
4/2018	FOXF1 Inhibits Pulmonary Fibrosis by Preventing CDH2-CDH11 Cadherin Switch in Myofibroblasts.
12/2017	FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vladimir V Kalinichenko Research Topics

Disease

25	Neoplasms (Cancer) 04/2024 - 01/2003
9	Pneumonia (Pneumonitis) 01/2023 - 10/2008
7	Persistent Fetal Circulation Syndrome 01/2023 - 09/2014
7	Carcinogenesis 01/2021 - 02/2005
6	Lung Injury 01/2023 - 06/2002
6	Fibrosis (Cirrhosis) 01/2020 - 01/2012
5	Lung Diseases (Lung Disease) 01/2023 - 07/2011
4	Rhabdomyosarcoma 01/2023 - 01/2017
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2023 - 01/2013
4	Hypertrophy 01/2021 - 01/2003
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 04/2004
3	Lung Neoplasms (Lung Cancer) 04/2024 - 02/2006
3	Hyperoxia 01/2023 - 05/2015
3	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 07/2011
3	Inflammation (Inflammations) 01/2022 - 05/2015
3	Liver Neoplasms (Liver Cancer) 01/2017 - 06/2005
2	Pulmonary Hypertension 03/2024 - 02/2024
2	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2023 - 09/2014
2	Hyperplasia 01/2023 - 11/2010
2	Idiopathic Pulmonary Fibrosis 01/2023 - 04/2018
2	Metaplasia 04/2017 - 01/2013
2	Chromosomal Instability (Chromosome Stability) 01/2017 - 01/2016
2	Adenocarcinoma 10/2016 - 02/2006
2	Prostatic Neoplasms (Prostate Cancer) 10/2016 - 02/2006
2	Adenocarcinoma of Lung 08/2009 - 02/2006
2	Osteosarcoma (Osteogenic Sarcoma) 07/2008 - 04/2004
2	Hemorrhage 03/2004 - 06/2002
1	Sarcoma (Soft Tissue Sarcoma) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Chorioamnionitis 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Tracheomalacia 12/2020
1	Rare Diseases (Rare Disease) 09/2020
1	Bronchopulmonary Dysplasia 01/2020
1	Rheumatoid Arthritis 12/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2019
1	Premature Birth (Birth, Premature) 01/2018
1	Obesity 12/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 12/2017
1	Adenoma (Adenomas) 12/2017

Drug/Important Bio-Agent (IBA)

30	Transcription Factors (Transcription Factor)IBA 01/2023 - 03/2004
12	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2002
6	RNA (Ribonucleic Acid)IBA 04/2024 - 05/2015
6	Messenger RNA (mRNA)IBA 01/2023 - 06/2002
5	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2023 - 01/2011
4	Small Interfering RNA (siRNA)IBA 01/2023 - 02/2006
4	Bleomycin (Blenoxane)FDA LinkGeneric 01/2023 - 03/2014
4	CollagenIBA 01/2023 - 04/2018
4	AllergensIBA 01/2019 - 10/2008
4	Forkhead Box Protein M1IBA 01/2019 - 02/2006
4	Urethane (Ethyl Carbamate)IBA 12/2017 - 02/2006
4	Butylated Hydroxytoluene (BHT)IBA 08/2009 - 06/2002
3	CateninsIBA 04/2024 - 01/2019
3	Complementary DNA (cDNA)IBA 04/2024 - 01/2021
3	AgarIBA 02/2006 - 04/2004
2	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 01/2023
2	ChromatinIBA 01/2023 - 01/2021
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023 - 10/2021
2	CytokinesIBA 01/2022 - 04/2017
2	Thiostrepton (Gargon)IBA 12/2019 - 01/2017
2	Cyclin D1IBA 01/2017 - 01/2011
2	Cyclin B1IBA 09/2014 - 09/2006
2	Peptides (Polypeptides)IBA 01/2007 - 02/2005
2	Phenobarbital (Luminal)FDA Link 01/2007 - 04/2004
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2007 - 04/2004
2	CarcinogensIBA 01/2007 - 02/2006
1	Drug CombinationsIBA 02/2024
1	Fatty Acid-Binding ProteinsIBA 02/2024
1	NucleotidesIBA 01/2023
1	EstersIBA 01/2023
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2023
1	indium-bleomycinIBA 01/2023
1	TransposasesIBA 01/2023
1	matrigelIBA 01/2023
1	5-(4-nitrophenyl)-2-furoic acid (NPFA)IBA 01/2023
1	tdTomatoIBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Transcription Activator-Like Effector NucleasesIBA 09/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2020
1	Carbon Tetrachloride (Tetrachloromethane)IBA 02/2019
1	alpha2 Subunit Collagen Type IIBA 02/2019
1	Cadherins (E-Cadherin)IBA 04/2018
1	TeratogensIBA 01/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2017
1	Blood Glucose (Blood Sugar)IBA 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 12/2017
1	Insulin (Novolin)FDA Link 12/2017
1	MucinsIBA 12/2017
1	Potassium Iodide (Pima)FDA Link 12/2017

Therapy/Procedure

16	Therapeutics 02/2024 - 04/2004
2	Transplantation 01/2024 - 01/2023
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 01/2021
2	Intravenous Administration 01/2023 - 01/2023
1	Cell Transplantation 01/2021
1	Critical Care (Surgical Intensive Care) 01/2020
1	Vagotomy 12/2017